THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN OF DRUG-RESISTANT TUBERCULOSIS IN INDIA

被引：0
|
作者：
Agnarson, M. A. [1 ]
Potluri, R. [2 ]
Bhandari, H. [3 ]
Dhir, A. [4 ]
Kumar, A. [3 ]
Gupta, V [5 ]
Raute, L. [5 ]
Shah, N. [5 ]
Kambili, C. [6 ]
Metz, L. [1 ]
机构：
[1] Johnson & Johnson, New Brunswick, NJ USA
[2] SmartAnalyst Inc, New York, NY USA
[3] SmartAnalyst India Pvt Ltd, Gurgaon, India
[4] SmartAnalyst India Pvt Ltd, Gurgaon, HR, India
[5] Janssen India, Mumbai, Maharashtra, India
[6] Johnson & Johnson, South Raritan, NJ USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN48
引用
收藏
页码：S648 / S648
页数：1
相关论文
共 50 条
  • [31] Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis
    Rangnekar, Bhamini
    Momin, Mohammad A. M.
    Eedara, Basanth Babu
    Sinha, Shubhra
    Das, Shyamal C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 570
  • [32] Establishing the Safety and Efficacy of Bedaquiline-Containing Regimen for the Treatment of Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Jihwaprani, Muhammad Candragupta
    Sun, Yipeng
    Rizky, Wahyu Choirur
    Sula, Idris
    Saquib, Nazmus
    PULMONARY MEDICINE, 2024, 2024
  • [33] HIV and body mass index are associated with prolonged corrected QT interval among people with drug-resistant tuberculosis on bedaquiline-containing regimen in Uganda
    Lodiong, Lodiong Jackson Dumo
    Izudi, Jonathan
    Amos, Timbine
    Twinomugisha, Bright
    Kulaba, Nicholas
    Lumori, Boniface Amanee Elias
    IJID REGIONS, 2024, 13
  • [34] Frequent acquisition of bedaquiline resistance by epidemic extensively drug-resistant Mycobacterium tuberculosis strains in Russia during long-term treatment
    Mokrousov, Igor
    Akhmedova, Gulnora
    Molchanov, Vladimir
    Fundovnaya, Elena
    Kozlova, Elena
    Ostankova, Yulia
    Semenov, Alexander
    Maslennikova, Natalia
    Leontev, Dmitrii
    Zhuravlev, Viacheslav
    Turkin, Eugeni
    Vyazovaya, Anna
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (03) : 478 - 480
  • [35] Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis
    Fu, Liang
    Weng, Taoping
    Sun, Feng
    Zhang, Peize
    Li, Hui
    Li, Yang
    Yang, Qianting
    Cai, Yi
    Zhang, Xilin
    Liang, Hancheng
    Chen, Xinchun
    Wang, Zhaoqin
    Liu, Lei
    Zhang, Wenhong
    Deng, Guofang
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 111 : 138 - 147
  • [36] Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India
    Udwadia, Z. F.
    Amale, R. A.
    Mullerpattan, J. B.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (11) : 1315 - 1318
  • [37] The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities
    Mingote, Laia Ruiz
    Namutamba, Dorothy
    Apina, Francis
    Barnabas, Nomampondo
    Contreras, Carmen
    Elnour, Taharqa
    Frick, Mike Watson
    Lee, Cynthia
    Seaworth, Barbara
    Shelly, Debra
    Skipper, Natalie
    dos Santos Filho, Ezio Tavora
    LANCET, 2015, 385 (9966): : 477 - 479
  • [38] Modeling the impact of bedaquiline treatment strategies on the multidrug-resistant tuberculosis burden in India
    Mehra, M.
    Kambili, C.
    Potluri, R.
    Rhines, A.
    Singh, V.
    Thomas, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (08) : 902 - 909
  • [39] Protocol for a systematic review of long-term physical sequelae and financial burden of multidrug-resistant and extensively drug-resistant tuberculosis
    Akalu, Temesgen Yihunie
    Clements, Archie C. A.
    Baraki, Adhanom Gebreegziabher
    Alene, Kefyalew Addis
    PLOS ONE, 2023, 18 (05):
  • [40] Bedaquiline-containing antituberculous regime-induced cutaneous adverse drug reactions: a 1-year prospective study from a nodal drug-resistant tuberculosis centre
    Pawar, M.
    Zawar, V.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 73 - 74
12345